Fetal tachycardia: a role for amiodarone as first- or second-line therapy?


BACKGROUND Fetal tachycardias result in serious prenatal and postnatal morbidity and mortality. Intrauterine treatment can improve prognosis dramatically and the therapeutic protocol is well defined. Currently, amiodarone is used as third-line therapy and is reserved for refractory cases. AIMS Our aim was to review the management and outcome of fetal… (More)
DOI: 10.1016/j.acvd.2008.08.012